Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-10 5:24 pm Purchase |
2025-03-03 | 13D | Pliant Therapeutics, Inc. PLRX |
TANG CAPITAL MANAGEMENT LLC | 5,859,044 9.600% |
5,859,044 (New Position) |
Filing History |
| 2025-03-07 10:01 am Sale |
2025-02-28 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 131,993 0.200% |
-3,831,424 (-96.67%) |
Filing History |
| 2025-02-14 8:01 pm Sale |
2024-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 2,895,478 4.800% |
-302,013 (-9.45%) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,197,491 5.300% |
500,843 (+18.57%) |
Filing History |
| 2024-11-14 5:05 pm Unchanged |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
Blue Owl Capital Holdings LP | 3,004,199 4.940% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:47 pm Sale |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
First Light Asset Management, LLC | 1,951,467 3.210% |
-1,726,543 (-46.94%) |
Filing History |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
PRICE T ROWE ASSOCIATES INC | 4,834,813 8.000% |
1,046,697 (+27.63%) |
Filing History |
| 2024-11-12 11:53 am Sale |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
Laurion Capital Management LP | 0 0.000% |
-3,583,567 (Position Closed) |
Filing History |
| 2024-10-04 5:34 pm Purchase |
2024-09-24 | 13G | Pliant Therapeutics, Inc. PLRX |
Paradigm BioCapital Advisors LP | 3,059,411 5.030% |
3,059,411 (New Position) |
Filing History |
| 2024-02-14 8:55 pm Purchase |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Blue Owl Capital Holdings LP | 3,004,199 5.020% |
3,004,199 (New Position) |
Filing History |
| 2024-02-14 5:10 pm Purchase |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
First Light Asset Management, LLC | 3,678,010 6.140% |
3,678,010 (New Position) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 2,696,648 4.500% |
-1,181,951 (-30.47%) |
Filing History |
| 2024-02-14 4:15 pm Unchanged |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Third Rock Ventures III L.P. | 2,132,867 3.600% |
0 (Unchanged) |
Filing History |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
PRICE T ROWE ASSOCIATES INC | 3,788,116 6.300% |
3,788,116 (New Position) |
Filing History |
| 2024-02-14 08:52 am Purchase |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Deep Track Capital, LP | 5,750,000 9.600% |
2,645,493 (+85.21%) |
Filing History |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Pliant Therapeutics, Inc. PLRX |
The Vanguard Group | 3,065,869 5.120% |
3,065,869 (New Position) |
Filing History |
| 2024-02-09 09:28 am Sale |
2024-02-08 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 3,963,417 6.617% |
-429,814 (-9.78%) |
Filing History |
| 2024-02-08 12:29 pm Purchase |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Laurion Capital Management LP | 3,583,567 5.980% |
3,583,567 (New Position) |
Filing History |
| 2024-01-25 4:59 pm Purchase |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
BLACKROCK INC BLK |
4,801,517 8.000% |
4,801,517 (New Position) |
Filing History |
| 2023-03-20 4:55 pm Purchase |
2023-03-10 | 13G | Pliant Therapeutics, Inc. PLRX |
Deep Track Capital, LP | 3,104,507 5.270% |
3,104,507 (New Position) |
Filing History |